Highlights IQ-AI Limited

Equities

Delayed London S.E. Other stock markets 15:52:41 17/05/2024 BST			5-day change	1st Jan Change
1.4 ^GBX	+3.70%		-15.15%	-70.21%

02:18pm	IQ-AI Unit Delivers Software to Insel Gruppe	MT
05-10	IQ-AI subsidiary gets rare paediatric disease designation FDA	AN

IQ-AI Unit Delivers Software to Insel Gruppe	01:18pm	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	05-02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	04-29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
IQ-AI shares sink on discounted placing fundraise	02-22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	02-09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	02-09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	02-02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	02-02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	01-10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	01-10	MT
IQ-AI Applies for FDA Pediatric Rare Disease Designation	11-08	CI
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	08/09/23	MT
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	18/08/23	MT
IQ-AI Shares Up 18% as Unit Strikes Commercial Deal with GE HealthCare	18/08/23	MT
IQ-AI shares jump on subsidiary's GE Healthcare deal	18/08/23	AN
IQ-AI Ltd Announces Update on Collaboration Agreement with Mayo Clinic	18/08/23	CI
IQ-AI interim loss narrows amid higher revenue, lower expenses	17/08/23	AN
Earnings Flash (IQAI.L) IQ-AI Reports H1 Revenue GBP282,652	17/08/23	MT
Earnings Flash (IQAI.L) IQ-AI Reports H1 Loss GBX-0.16	17/08/23	MT

No results for this search